KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) Net Margin (2016 - 2025)

LifeMD filings provide 14 years of Net Margin readings, the most recent being 271.0% for Q4 2025.

  • On a quarterly basis, Net Margin rose 40735.0% to 271.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.75%, a 2606.0% increase, with the full-year FY2025 number at 5.8%, up 2277.0% from a year prior.
  • Net Margin hit 271.0% in Q4 2025 for LifeMD, up from 7.62% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 271.0% in Q4 2025 to a low of 136.35% in Q4 2024.
  • Median Net Margin over the past 5 years was 19.38% (2023), compared with a mean of 20.49%.
  • Biggest five-year swings in Net Margin: tumbled -12630bps in 2024 and later surged 40735bps in 2025.
  • LifeMD's Net Margin stood at 69.24% in 2021, then skyrocketed by 35bps to 45.21% in 2022, then surged by 78bps to 10.05% in 2023, then tumbled by -1257bps to 136.35% in 2024, then soared by 299bps to 271.0% in 2025.
  • The last three reported values for Net Margin were 271.0% (Q4 2025), 7.62% (Q3 2025), and 0.93% (Q2 2025) per Business Quant data.